NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial). (Q33356751)

26 July 2017

title

NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial). (English)

1 reference

26 July 2017

1 reference

Ronald Boellaard

16

0 references

Patrick Bossuyt

6

object named as

Patrick M M Bossuyt

1 reference

26 July 2017

7

Otto S Hoekstra

1 reference

26 July 2017

5

Hugo W Tilanus

1 reference

26 July 2017

4

Olivier R C Busch

1 reference

26 July 2017

Mark van Heijl

1

1 reference

26 July 2017

Jikke M T Omloo

2

1 reference

26 July 2017

Mark I van Berge Henegouwen

3

1 reference

26 July 2017

Jaap Stoker

8

1 reference

26 July 2017

Maarten C C M Hulshof

9

1 reference

26 July 2017

Ate van der Gaast

10

1 reference

26 July 2017

Grard A P Nieuwenhuijzen

11

1 reference

26 July 2017

Han J Bonenkamp

12

1 reference

26 July 2017

John Th M Plukker

13

1 reference

26 July 2017

Ernst J Spillenaar Bilgen

14

1 reference

26 July 2017

Fibo J W Ten Kate

15

1 reference

26 July 2017

Jan Pruim

17

1 reference

26 July 2017

Gerrit W Sloof

18

1 reference

26 July 2017

J Jan B van Lanschot

19

1 reference

26 July 2017

language of work or name

1 reference

31 July 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

8

1 reference

26 July 2017

page(s)

3

1 reference

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-6649-8-3

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-6649-8-3

Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-6649-8-3

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-6649-8-3

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-6649-8-3

The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-6649-8-3

Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-6649-8-3

Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-6649-8-3

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Computing sample size for receiver operating characteristic studies.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301128

Hospital volume and hospital mortality for esophagectomy

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18671847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18671847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18671847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1756-6649-8-3

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference